8U8A

Cryo-EM structure of LRRK2 bound to type II inhibitor ponatinib

Summary for 8U8A

• Entry DOI: 10.2210/pdb8u8a/pdb
• EMDB information: 42019
• Descriptor: Leucine-rich repeat serine/threonine-protein kinase 2, 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam ide, GUANOSINE-5'-DIPHOSPHATE (3 entities in total)
• Functional Keywords: cryo-em, parkinson's disease, kinase, lrrk2, type ii inhibitor, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
• Biological source: Homo sapiens (human)
• Total number of polymer chains: 2
• Total formula weight: 574806.83

Authors

Zhu, H.,Sun, J. (deposition date: 2023-09-16, release date: 2024-01-31)

• Primary citation: Zhu, H.,Hixson, P.,Ma, W.,Sun, J.; Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM.; Cell Discov, 10:10-10, 2024; PubMed: 38263358; DOI: 10.1038/s41421-023-00639-8

Experimental method

ELECTRON MICROSCOPY (3.4 Å)